Contact this trialFirst, we need to learn more about you.
Antibody Drug Conjugate
ADCT-301 for Stomach Cancer
Recruiting1 awardPhase 1
San Antonio, Texas
This trial is testing a new cancer drug in patients with advanced solid tumors. Patients will take the drug every 3 weeks for a year, then be monitored every 12 weeks.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.